Skip to main content

Advertisement

Table 2 Positive likelihood ratio in predicting the large-joint-dominant patients

From: Joint index vector: a novel assessment measure for stratified medicine in patients with rheumatoid arthritis

Transformation matrix derived from patients Target patients in 2015
All disease duration MTX
< 10 years ≥ 10 years Users Non-users
Of all 5.9 6.0 5.6 6.6 5.8
With disease duration (years)
 < 10 6.8 7.5 5.9 7.5 6.9
 ≥ 10 5.3 5.5 4.9 5.7 5.4
Treated
 With MTX 6.4 6.6 6.0 7.2 6.3
 Without MTX 4.9 5.0 4.5 5.2 5.0
  1. The large-joint-dominant patients of 2016 were predicted with estimated vectors from various target patients in 2015 using different transformation matrices derived from the joint index vectors of patient data serially registered in 2013 and 2014
  2. MTX methotrexate